BioSpace News Archive

Pharm Country

Actinium Announces Participation at the 2019 Cell & Gene Meeting on the Mesa

Actinium to highlight its Iomab-ACT program for targeted lymphodepletion for CAR-T and other adoptive cell therapies

September 30, 2019
·
5 min read
Business

Vertex and Ribometrix Establish Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics

Vertex Pharmaceuticals Incorporated and RNA therapeutics developer Ribometrix, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel RNA-targeted small molecule therapeutic candidates for serious diseases.

September 30, 2019
·
6 min read
Business

Evotec And Indivumed Achieve Milestone In Joint Strategic Drug Discovery Collaboration

Evotec SE and Indivumed GmbH announced that the first milestone has been successfully achieved in their joint collaboration to identify new therapeutic targets for the treatment of colorectal cancer.

September 30, 2019
·
6 min read
Pharm Country

UroGen To Present at October 2019 Investor Conference

UroGen Pharma Ltd., a clinical-stage biopharmaceutical company developing treatments to address unmet needs in uro-oncology, announced that it will present at the following conference in October

September 30, 2019
·
1 min read
Policy

Moderna Announces Open IND for Propionic Acidemia Program (mRNA-3927)

Moderna, Inc. announced the U.S. Food and Drug Administration has completed their review of the Investigational New Drug application for mRNA-3927, its investigational mRNA therapeutic for propionic acidemia and allowed it to proceed to clinic.

September 30, 2019
·
7 min read
Business

RMS Medical Products Names R. John Fletcher Chairman of the Board

Repro Med Systems, Inc. dba RMS Medical Products announced that R. John Fletcher has been appointed Chairman of the Board.

September 30, 2019
·
3 min read
Genetown

Stoke Therapeutics to Present at 2019 Cantor Global Healthcare Conference

Stoke Therapeutics, Inc. announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 at 10:05 a.m. Eastern time in New York, New York.

September 30, 2019
·
1 min read
Policy

Miller Law LLC, Hilliard & Shadowen LLP, Motley Rice LLC, and Cohen Milstein Sellers & Toll PLLC Announce Notice of Class Action for In re Loestrin 24 Fe Antitrust Litigation

If You Purchased Loestrin 24 Fe, Minastrin 24 Fe and/or Their Generic Equivalent(s) a Class Action Lawsuit May Affect Your Rights

September 30, 2019
·
3 min read
Policy

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - MYGN

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Myriad Genetics, Inc. from September 2, 2016 through August 13, 2019, inclusive.

September 30, 2019
·
3 min read
Policy

MYGN Loss Alert: Hagens Berman Notifies Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit

Class-action law firm urges MYGN investors who have suffered losses of 50K+ to learn their shareholder rights

September 30, 2019
·
2 min read